{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:41:23Z","timestamp":1792795283502,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jhep.2017.03.014","type":"journal-article","created":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T04:00:34Z","timestamp":1490328034000},"page":"224-236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":124,"title":["Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses"],"prefix":"10.1016","volume":"67","author":[{"given":"Tania M.","family":"Welzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeru","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Hedskog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Chodavarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Camus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McNally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Brainard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evguenia","family":"Svarovskaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Zeuzem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosh","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2017.03.014_b0005","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhep.2017.03.014_b0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2017.03.014_b0015","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.03.014_b0020","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.3748\/wjg.v13.i36.4808","article-title":"Sequence diversity of hepatitis C virus: implications for immune control and therapy","volume":"13","author":"Timm","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2017.03.014_b0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/liv.13027","article-title":"Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives","volume":"36","author":"Asselah","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2017.03.014_b0030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1306218","article-title":"Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection","volume":"370","author":"Sulkowski","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2017.03.014_b0035","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","article-title":"Sofosbuvir for previously untreated chronic hepatitis C infection","volume":"368","author":"Lawitz","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2017.03.014_b0040","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa1512610","article-title":"Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection","volume":"373","author":"Feld","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2017.03.014_b0045","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1056\/NEJMoa1512612","article-title":"Sofosbuvir and velpatasvir for HCV genotype 2 and 3 infection","volume":"373","author":"Foster","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2017.03.014_b0050","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"Gower","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.03.014_b0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes","volume":"61","author":"Messina","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.03.014_b0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1479-0556-9-2","article-title":"Hepatitis C virus genotype 3a with phylogenetically distinct origin is circulating in Pakistan","volume":"9","author":"Rehman","year":"2011","journal-title":"Genet Vaccines Ther"},{"key":"10.1016\/j.jhep.2017.03.014_b0065","doi-asserted-by":"crossref","first-page":"11223","DOI":"10.1128\/JVI.02106-15","article-title":"Spatiotemporal reconstruction of the introduction of hepatitis C virus into Scotland and its subsequent regional transmission","volume":"89","author":"McNaughton","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2017.03.014_b0070","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000351621","article-title":"Molecular epidemiology and genetic history of hepatitis C virus subtype 3a infection in Thailand","volume":"56","author":"Akkarathamrongsin","year":"2013","journal-title":"Intervirology"},{"key":"10.1016\/j.jhep.2017.03.014_b0075","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/hepr.12505","article-title":"High incidence of the hepatitis C virus recombinant 2k\/1b in Georgia: Recommendations for testing and treatment","volume":"45","author":"Karchava","year":"2015","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2017.03.014_b0080","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1128\/JVI.06184-11","article-title":"Origin and evolution of the unique hepatitis C virus circulating recombinant form 2k\/1b","volume":"86","author":"Raghwani","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2017.03.014_b0085","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1128\/JVI.76.8.4034-4043.2002","article-title":"A natural intergenotypic recombinant of hepatitis C virus identified in St Petersburg","volume":"76","author":"Kalinina","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2017.03.014_b0090","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1093\/infdis\/jis761","article-title":"Antiviral resistance and the future landscape of hepatitis C virus infection therapy","volume":"207","author":"Wyles","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2017.03.014_b0095","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/1743-422X-10-355","article-title":"Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naive patients","volume":"10","author":"Paolucci","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.jhep.2017.03.014_b0100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.antiviral.2015.01.003","article-title":"Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European region","volume":"116","author":"Sarrazin","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jhep.2017.03.014_b0105","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1099\/0022-1317-74-6-1093","article-title":"Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay","volume":"74","author":"Stuyver","year":"1993","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2017.03.014_b0110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0168-1702(95)00052-R","article-title":"Hepatitis C virus genotyping by means of 5'-UR\/core line probe assays and molecular analysis of untypeable samples","volume":"38","author":"Stuyver","year":"1995","journal-title":"Virus Res"},{"key":"10.1016\/j.jhep.2017.03.014_b0115","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","article-title":"Gapped BLAST and PSI-BLAST: a new generation of protein database search programs","volume":"25","author":"Altschul","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhep.2017.03.014_b0120","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1128\/JCM.02624-14","article-title":"Genotype- and subtype-independent full-genome sequencing assay for hepatitis C virus","volume":"53","author":"Hedskog","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jhep.2017.03.014_b0125","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1093\/nar\/22.22.4673","article-title":"CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice","volume":"22","author":"Thompson","year":"1994","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhep.2017.03.014_b0130","series-title":"Genetic algorithm approaches for the phylogenetic analysis of large biological sequence datasets under the maximum likelihood criterion","author":"Zwickl","year":"2006"},{"key":"10.1016\/j.jhep.2017.03.014_b0135","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/10635150600755453","article-title":"Approximate likelihood-ratio test for branches: A fast, accurate, and powerful alternative","volume":"55","author":"Anisimova","year":"2006","journal-title":"Syst Biol"},{"key":"10.1016\/j.jhep.2017.03.014_b0140","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/sysbio\/syq010","article-title":"New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0","volume":"59","author":"Guindon","year":"2010","journal-title":"Syst Biol"},{"key":"10.1016\/j.jhep.2017.03.014_b0145","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/hep.27361","article-title":"Characterization of hepatitis C virus intergenotypic recombinant strains and associated virological response to sofosbuvir\/ribavirin","volume":"61","author":"Hedskog","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhep.2017.03.014_b0150","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28636","article-title":"Treatment of a patient with genotype 7 HCV infection with sofosbuvir and velpatasvir","volume":"64","author":"Schreiber","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.03.014_b0155","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(99)06527-7","article-title":"The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt","volume":"355","author":"Frank","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2017.03.014_b0160","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/cld.332","article-title":"Recent FDA approval of sofosbuvir and simeprevir. Implications for current HCV treatment","volume":"3","author":"Lin","year":"2014","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2017.03.014_b0165","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/hep.27113","article-title":"Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection","volume":"59","author":"Kumada","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.03.014_b0170","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.3748\/wjg.v20.i11.2902","article-title":"Hepatitis C virus NS5A inhibitors and drug resistance mutations","volume":"20","author":"Nakamoto","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2017.03.014_b0175","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1128\/AAC.00054-12","article-title":"Genotype and subtype profiling of PSI-7977 as a nucleotide inhibitor of hepatitis C virus","volume":"56","author":"Lam","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2017.03.014_b0180","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1128\/JCM.01982-06","article-title":"Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay","volume":"45","author":"Bouchardeau","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jhep.2017.03.014_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2015.10.010","article-title":"Diagnosis of hepatitis C virus genotype 2k\/1b needs NS5B sequencing","volume":"41","author":"De Keukeleire","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jhep.2017.03.014_b0190","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1128\/JCM.01122-06","article-title":"Genotyping hepatitis C viruses from Southeast Asia by a novel line probe assay that simultaneously detects core and 5' untranslated regions","volume":"44","author":"Noppornpanth","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jhep.2017.03.014_b0195","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/infdis\/jiv564","article-title":"L159F and V321A sofosbuvir-associated hepatitis C virus NS5B substitutions","volume":"213","author":"Svarovskaia","year":"2016","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.jhep.2017.03.014_b0200","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/hep.28706","article-title":"Ledipasvir plus sofosbuvir for 12 weeks in patients with hepatitis C genotype 4 infection","volume":"64","author":"Abergel","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.03.014_b0205","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jhep.2017.01.007","article-title":"NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: prevalence and effect on treatment outcome","volume":"66","author":"Zeuzem","year":"2017","journal-title":"J Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827817301484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827817301484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T07:57:23Z","timestamp":1535961443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827817301484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0168827817301484"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2017.03.014","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2017.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}